The present review discusses the diagnostic strategies, rationale, treatment strategies and prospects of targeted therapy and immunotherapy for ovarian cancer.Li, XuejiaoLi, ZhuochengMa, HuilingLi, XinweiZhai, HongxiaoLi, XixiCheng, XiaofeiZhao, Xiaohui...
Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence Article Open access 29 July 2020 Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma Ar...
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to platinum-based chemotherapy. However, the majority of patients relapse following initial surgery and chemotherapy, highlighting the urgent need to develop new therapeutic strategies. I...
EP. 1:Initial Therapy Options for Advanced Ovarian Cancer Rebecca Previs, MD April 1st 2021 Dr. Rebecca Previs reviews first line treatment options for patients with advanced ovarian cancer. EP. 2:Role of Bevacizumab for Initial Therapy in Advanced Ovarian Cancer ...
doi: 10.20892/j.issn.2095-3941.2016.0084 REVIEW Epidemiology of ovarian cancer: a review Brett M. Reid, Jennifer B. Permuth, Thomas A. Sellers Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa 33612, FL, USA ABSTRACT KEYWORDS Ovarian cancer (...
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review Cardiovascular toxicity is a potential short- or long-term complication of anticancer therapy. Exposure to chemotherapy medications, primarily the anthracy... G Curigliano,EL Mayer,A Goldhirsch - 《Progress in Cardiovascular Diseases》...
The term “immunotherapy” envelops monoclonal antibodies as receptor mediators, including immune checkpoint inhibitors (ICPI), cancer vaccines, and adoptive immunotherapies alone or in combination with other therapeutic approaches. The purpose of this review is to summarize the status of immunotherapy ...
5-methyltetrahydrofolate (5-MTHF) supplementation is not recommended concurrent with methotrexate cancer therapy, as it can interfere with methotrexate's anti-neoplastic activity; however, this folate source has not been shown to interfere with the anti-inflammatory activity of methotrexate. An individua...
The epidemiology of ovarian cancer: a review Ovarian cancer is difficult to detect in an early stage when cure rates are higher. Because of this, it is important to identify women who may have a greater probability of developing the disease. The question of what factors influence a... LH ...
Non-genetic risk factors for ovarian cancer include advanced age, postmenopausal hormone therapy (especially >5 years), and obesity or weight gain. Diet, nonsteroidal anti-inflammatory medicines, talc exposure and smoking have all been linked to infertility, but the impact of infertility drugs is ...